News

CEO of Front Range Biosciences Reacts To First Public FDA Hearing On Sale of CBD

May 31, 2019

Cheddar Interview with Dr. Jonathan Vaught
Chloe Aiello, Reporter at Cheddar, interviews Dr. Jonathan Vaught, CEO and Co-Founder of FRB.

On Friday, May 31, Dr. Jonathan Vaught, CEO and Co-Founder of Front Range Biosciences, presented at the FDA hearing on Products Containing Cannabis or Cannabis-Derived Compounds. His testimony at the FDA hearing focused on the current data backing the safety of cannabinoid products, positive agricultural impacts, and the segments of the U.S. economy that would thrive with the commercialization of cannabis and cannabis-derived compounds.

This exposure from speaking on behalf of the cannabis industry has increased our media attention. As a result, Cheddar interviewed Dr. Vaught on his insights discussing the hearing and constructive steps for moving forward.

Watch the full interview with Cheddar here.


ADDITIONAL INFORMATION:
  • Searching for cannabinoid-rich hemp plants? To view our current availability for cannabinoid-rich clones from our Clean Stock® program, as well as our seedlings and feminized seeds, contact our sales team at: sales@frontrangebio.com or complete an order inquiry at: https://www.frontrangebio.com/inquire
  • Stay up-to-date with FRB’s current events and information by following our Resources page